M. Nietosampedro et al., EXPERIMENTAL BRAIN GLIOMA - GROWTH ARREST AND DESTRUCTION BY A BLOOD-GROUP-RELATED TETRASACCHARIDE, Journal of neuropathology and experimental neurology, 55(2), 1996, pp. 169-177
A synthetic tetrasaccharide (TSI), structurally related to blood group
s, inhibited the proliferation of C6 glioma cells in culture and the g
rowth of tumors formed after intracerebral transplantation of C6 cells
. TS4-treated tumors were substantially smaller than controls, as expe
cted from TS4 cytostatic action on C6 glioma cells in culture. However
, in vivo treatment also caused extensive tumor destruction. This effe
ct appeared to be caused indirectly, either by activation of natural k
iller cells, cytotoxic lymphocytes, or by inhibition of tumor vascular
ization. Enhanced antigenicity of TS4-treated glioma may be related to
the increased expression of connexin 43 observed in glioma cell cultu
res treated with the oligosaccharide. Because concentrations of up to
20 mg/ml of TS4 were not toxic for normal neuronal or glial cells, spe
cific oligosaccharides such as TS4 offer the possibility of selective
tumor treatment.